Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).
Saved in:
| Title: | Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS). |
|---|---|
| Authors: | Mo A; Transfusion Research Unit, School of Public Health & Preventive Medicine, Monash University, Melbourne, Australia.; Department of Haematology, Monash Health, Clayton, Australia.; Austin Health, Melbourne, Australia., Poynton M; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Kimber C; Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK.; Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK., Csenar M; Institute of Public Health, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany., Dorée C; Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK., Prodger C; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Stanworth S; Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Radcliffe Department of Medicine, University of Oxford, Oxford, UK., McQuilten Z; Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. |
| Source: | The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2026 Jul 03; Vol. 7. Cochrane AN: CD016362. Date of Electronic Publication: 2026 Jul 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X (Electronic) Linking ISSN: 13616137 NLM ISO Abbreviation: Cochrane Database Syst Rev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
